BACKGROUND Despite major advances in its prevention and treatment, febrile neutropenia remains a most concerning complication of cancer chemotherapy. Outside the oncology setting, however, only few data are currently available on febrile neutropenia related to non-chemotherapy drugs. We report here data on 76 patients with febrile neutropenia related to non-chemotherapy drugs, followed up in a ...

BACKGROUND: Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. Febrile neutropenia one of medical emergencies ALL patients. One risk factors that associate with febrile malnutrition. Malnutrition reduce body’s immunity increase incidence infection.
 AIM: aimed to prove malnutrition as factor children who had neutropenia
 METHOD: This case-control study sampl...

objective: to evaluate the potential advantages of imipenem/cilastatin in control of fever in neutro-penic hsct recipients.patients and method: in this single-center study, 111 consecutive febrile episodes in 104 neutropenic hsct recipients with a mean age of 26 years were randomized to treatment either with imipenem/cilastatin 1 g, iv, q8h or cefepime (our standard regimen) 2 g, iv, q8h. if fe...

Febrile neutropenia is a serious adverse effect of chemotherapy. It can lead to complications and death, as well delays in treatment, chemotherapy dose reductions, compromised treatment efficacy, reduced survival. The assessment the patient-related risk factors plays significant role prevention febrile its complications. In case intermediate-risk chemotherapy, contribute estimation an overall t...

Introduction: Several side effects may occur during cancer treatment such as myelosuppression following systemic chemotherapy, which is mainly manifested neutropenia and associated with increased infection risk. Febrile a worse prognosis. Granulocyte colony-stimulating factor (G-CSF) be given prophylactically before chemotherapy in selected cases or adjuvant therapy febrile neutropenia. G-CSF a...

OBJECTIVES To assess safety and efficacy of JiSaiXin (Recombinant Human Granulocyte Colony Stimulating Factor Injection manufactured in China, G-CSF) 150ug per day for three days and whether this regimen could reduce the incidence of febrile neutropenia caused by chemotherapy. METHOD From July 2014 to December 2014 patients treated by chemotherapy in our hospital were randomly divided into tw...

Febrile neutropenia is common chemotherapy complication significantly impacting patient's outcomes, quality of life and costs, too. Febrile neutropenia (FN) often leads to hospitalization, the need for intravenous antibiotics and use of granulocyte colony-stimulating factors (GCSF) in order to avoid its complications. Cost of febrile neutropenia is well described in literature, but no study has...

Bacterial Pathogens Bacteria are the predominant organisms. In the late 1950’s/early 1960’s Gram+ve organisms were the commonest, particularly Staphylococcus aureus. The late 1960’s/early 1970’s were typified by Gram-ve of gastrointestinal tract origin, particularly Escherischia coli, Klebsiella spp and Pseudomonas spp. By the 1990’s Staphylococcus spp including coagulase negative organisms, St...